Meta-analysis of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Bioprosthetic Valves

Am J Cardiol. 2021 Mar 1:142:140-141. doi: 10.1016/j.amjcard.2020.12.006. Epub 2020 Dec 4.

Authors

Babikir Kheiri¹, Ryle Przybylowicz¹, Timothy F Simpson¹, Hani Alhamoud², Mohammed Osman², Khidir Dalouk¹, Babak Nazer¹, Charles A Henrikson¹, Eric Stecker³

Affiliations

¹ Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
² Division of Cardiology, West Virginia University School of Medicine, Morgantown, West Virginia.
³ Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: steckere@ohsu.edu.

PMID: 33285096
DOI: 10.1016/j.amjcard.2020.12.006

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Anticoagulants / therapeutic use
Atrial Fibrillation / complications
Atrial Fibrillation / drug therapy*
Bioprosthesis*
Factor Xa Inhibitors / therapeutic use*
Heart Valve Prosthesis*
Humans
Proportional Hazards Models
Stroke / etiology
Stroke / prevention & control*
Thromboembolism / etiology
Thromboembolism / prevention & control*
Warfarin / therapeutic use*

Substances

Anticoagulants
Factor Xa Inhibitors
Warfarin